Northern California Chapter of GAPNA

GAPNA Contemporary Pharmacology and Prescribing in Older Adults Conference

Sheraton Philadelphia Downtown Hotel
201 North 17th Street
Philadelphia, PA 19103

Friday, March 27, 2015 at 7:45am ET - Saturday, March 28, 2015 at 4:00pm ET
This event has ended.

Posted by The Texas GAPNA

201 North 17th Street, Philadelphia, PA 19103

Info

Attachments

Additional Information

This conference will enable attendees to:
  • Determine appropriate pharmacotherapeutic agents for selected disease states in older adults
  • Discuss the phamacodynamic and pharmacokinetic considerations surrounding selection of pharmacotherapeutic agents in older adults
  • Design safe and appropriate pharmacotherapeutic regimens for older adults with selected disease states
What You Can Expect:
  • Eight sessions designed to offer choice and variety
  • Educational interactions with leading industry representatives
  • Indefinite Online Library access
  • Opportunities to network with colleagues from across the country
  • Earn up to 11.5 CNE contact hours
  • Earn 11.5 pharmacology contact hours

Event Agenda

GAPNA Contemporary Pharmacology and Prescribing in Older Adults Conference

Event Agenda

Friday, March 27, 2015 at 7:45am ET - Saturday, March 28, 2015 at 4:00pm ET

All times listed in Eastern Time (US & Canada).
Download event agenda (PDF)

Friday, March 27, 2015

  • 7:45am - 6:30pm

    Registration Open

  • 7:45am - 8:45am

    Continental Breakfast/Networking

  • 8:45am - 10:15am

    101: Pharmacogenomics:What’sinYourGenes Matters!

    Calvin H. Knowlton, PhD, MDiv, BSPharm
    1.5 CE Credits

    In order to reduce medication misadventures, especially preventable adverse drug events, the migration from preference-based and evidence- based (or population-based) medication selection to personalization of such incorporates an array of science-centered components, including
    pharmacogenomics. This session will explore an overview of these components, while discussing in-depth the emerging domain of pharmacogenomics.

  • 10:15am - 10:45am

    Coffee Break/Networking

  • 10:45am - 11:45am

    102: Medication Therapy for Pulmonary Disease in Older Adults

    Maureen George, PhD, RN, AE-C, FAAN
    1.0 CE Credit

    This session will compare and contrast asthma and COPD to identify similarities and differences in pharmacologic management by comparing the recommendation from evidence-based guidelines based on age and severity.

  • 12:00pm - 1:00pm

    Industry-Supported Presentation Theater

    Supported by AstraZeneca

    No continuing education credit will be provided for this event.

  • 1:00pm - 2:30pm

    General Session 103: Medication Therapy for Hypercholesterolemia

    Neil Stone, MD, MACP, FAHA, FACC
    1.5 CE Credits

    This session will review the latest 2013 Prevention Guidelines from ACC and AHA and will explore, through case studies, the role of the nurse clinician in evaluation and treatment of appropriate patients.

  • 2:30pm - 3:30pm

    104: Medical Management of Heart Failure

    Lisa Rathman, MSN, CRNP, CHFN, CCRN
    1.0 CE Credit

    Heart failure is a common clinical syndrome representing the end stage of a number of different cardiac diseases. It is the leading cause of hospitalization in the elderly and is accompanied by high direct and indirect costs for treatment. This session will provide a comprehensive overview of the current strategies for the pharmacologic treatment of heart failure.

  • 3:30pm - 4:00pm

    Refreshment Break/Networking

  • 4:00pm - 5:30pm

    105: Antibiotic Prescribing in Older Adults in the Era of Antimicrobial Resistance

    Jason Gallagher, PharmD, FCCP, BCPS
    1.5 CE Credits

    This session will discuss the safety and efficacy in the use of antibiotics in older adults. Issues regarding the treatment of bacterial infections in patients with resistant infections and a discussion of the “downstream” consequences of antimicrobial use will be included.

  • 5:30pm - 6:30pm

    106: An Update in Approaches to Glycemic Management for Older Patients with Type 2 Diabetes

    Tyan Thomas, PharmD, BCPS
    1.0 CE Credit

    This session will serve as a brief overview of the current treatment guidelines for older people with type 2 diabetes. Discussion will include evidence of cardiovascular risk factor improvement with GLP-1 analogs and DPP-IV inhibitors and agents for type 2 diabetes recently brought to market or currently being studied.

Saturday, March 28, 2015

  • 7:00am - 12:30pm

    Registration Open

  • 7:00am - 8:00am

    Continental Breakfast

  • 8:00am - 9:00am

    201: Alcohol and Substance Addiction in Later Years

    David Oslin, MD
    1.0 CE Credit

    This session will explore the issues related to addiction in the older adult population. There will be an emphasis on the epidemiology of alcohol and opioid abuse and methods for screening/ assessment particularly in nonpsychiatric settings such as primary care or hospitals. Treatment options in all types of care settings will also be discussed.

  • 9:00am - 9:15am

    Coffee Break

  • 9:15am - 12:15pm

    202: Pain Management and Opioid Prescribing

    Rasham Shah-Ortiz, PharmD Deborah Way, MD, CMD, FAAHPM
    3.0 CE Credits

    This interactive 3-hour didactic and case-based session will provide a review of pharmacotherapy of pain management. The focus will be on the unique needs of the geriatric patient across the care continuum.